Welcome to Psoriasis Guide
Treatment For Psoriasis Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
The Causes, Symptoms and Treatments for Plaque Psoriasis
from:The occurrence of plaque psoriasis is not a rare thing. In fact, plaque psoriasis is the most common type of psoriasis around, and psoriasis is said to infect at least 2% of the present population in the US. Plaque psoriasis is a disease that manifests itself on certain parts of a person's anatomy, and usually these manifestations come in the form of red, scaly blotches that are either itchy or pretty unsightly to look at. How does one get plaque psoriasis and what can be done to help a person get over the symptoms of this disease?
The disease known as plaque psoriasis is usually acquired through heredity, although there are also indications that the disease can develop in people that are HIV positive, smokers or drug users. There are also indications that plaque psoriasis can occur in people who are stressed out, alcohol drinkers, or those who are exposed to too much sunlight. While these factors may indeed trigger the emergence of psoriasis, the usual reason for a person having psoriasis is due to the fact that his or her parents have it. The possibility of a child developing psoriasis rises if both parents have the disease and it diminishes slightly when only one parent has the skin problem.
Plaque psoriasis often manifests itself first as a reddish rash or burn that may or may not itch. These very red patches of skin may eventually develop a scaly scab that when peeled off will reveal a reddish skin that may bleed or crack. The scales and plaques that this kind of psoriasis causes may appear anywhere on a person's body, and it may cause discomfort, pain or even infection if it is not taken care of. These flare-ups usually last around a few weeks to as long as a few months, and they may recur after a few months of living without any flare-ups.
Treatments for plaque psoriasis vary according to the severity of the affliction, and they are available in either combination treatments or solo treatments. There are topical medications, oral or systemic treatments, and photo therapy treatments that can help with the flare-ups that a psoriasis sufferer experiences. These can be administered in conjunction with one another, depending on how severe a psoriasis case may be. The topical medications can also be purchased as over the counter medications, or as prescription creams and ointments, depending on what the attending physician advises the patient to do. Systemic treatments can come in either oral or injection forms while photo therapy usually uses either UV rays or laser to help get rid of the flare-ups on a person’s skin.
Treatment For Psoriasis News
XenoPort Submits Investigational New Drug Application for XP23829 as a ... - MarketWatch (press release)
XenoPort Submits Investigational New Drug Application for XP23829 as a ... MarketWatch (press release) In addition to our filing the IND to initiate human clinical trials for the potential treatment of RRMS, we also recently demonstrated that XP23829 and related compounds were effective in an animal model of psoriasis. We are hopeful that our first ... |
The Overall Psoriasis Drug Market Will Increase from $4.1 Billion in 2010 to ... - MarketWatch (press release)
The Overall Psoriasis Drug Market Will Increase from $4.1 Billion in 2010 to ... MarketWatch (press release) BURLINGTON, Mass., May 21, 2012 (BUSINESS WIRE) -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe psoriasis, ... |
NEOVA®'s Technology featured on THE Doctors show - MarketWatch (press release)
NEOVA®'s Technology featured on THE Doctors show MarketWatch (press release) (TM) brand, for various indications including hair removal, acne treatment and skin rejuvenation. The company also offers a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and ... |
VBL Therapeutics Presents Positive Preclinical Data for VB-201 in Inflammatory ... - MarketWatch (press release)
VBL Therapeutics Presents Positive Preclinical Data for VB-201 in Inflammatory ... MarketWatch (press release) TEL AVIV, Israel & SAN DIEGO, May 21, 2012 (BUSINESS WIRE) -- VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced data demonstrating ... |
Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical ... - MarketWatch (press release)
Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical ... MarketWatch (press release) In autoimmune diseases, Idera is developing inhibitors of TLRs 7, 8, and 9 for the potential treatment of psoriasis, lupus, and other diseases. Idera's lead clinical candidate is IMO-3100, an antagonist of TLR7 and TLR9, which is in Phase 2 development ... Idera Reports Data From Preclinical Studies Of IMO-8400 - Quick Facts |